Skip to main content
Erschienen in: Pharmaceutical Medicine 5/2011

01.10.2011 | Review Article

Advances in Gene Delivery Systems

verfasst von: Kenya Kamimura, Takeshi Suda, Guisheng Zhang, Professor Dexi Liu

Erschienen in: Pharmaceutical Medicine | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

The transfer of genes into cells, both in vitro and in vivo, is critical for studying gene function and conducting gene therapy. Methods that utilize viral and nonviral vectors, as well as physical approaches, have been explored. Viral vector-mediated gene transfer employs replication-deficient viruses such as retrovirus, adenovirus, adeno-associated virus and herpes simplex virus. A major advantage of viral vectors is their high gene delivery efficiency. The nonviral vectors developed so far include cationic liposomes, cationic polymers, synthetic peptides and naturally occurring compounds. These nonviral vectors appear to be highly effective in gene delivery to cultured cells in vitro but are significantly less effective in vivo. Physical methods utilize mechanical pressure, electric shock or hydrodynamic force to transiently permeate the cell membrane to transfer DNA into target cells. They are simpler than viral- and nonviral-based systems and highly effective for localized gene delivery. The past decade has seen significant efforts to establish the most desirable method for safe, effective and target-specific gene delivery, and good progress has been made. The objectives of this review are to (i) explain the rationale for the design of viral, nonviral and physical methods for gene delivery; (ii) provide a summary on recent advances in gene transfer technology; (iii) discuss advantages and disadvantages of each of the most commonly used gene delivery methods; and (iv) provide future perspectives.
Literatur
1.
Zurück zum Zitat Blaese RM, Culver KW, Miller AD, et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270: 475–80PubMedCrossRef Blaese RM, Culver KW, Miller AD, et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270: 475–80PubMedCrossRef
2.
Zurück zum Zitat Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346–58PubMedCrossRef Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346–58PubMedCrossRef
3.
Zurück zum Zitat Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33–40PubMedCrossRef Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33–40PubMedCrossRef
4.
Zurück zum Zitat Barquinero J, Eixarch H, Perez-Melgosa M. Retroviral vectors: new applications for an old tool. Gene Ther 2004; 11 (Suppl. 1): S3–9PubMedCrossRef Barquinero J, Eixarch H, Perez-Melgosa M. Retroviral vectors: new applications for an old tool. Gene Ther 2004; 11 (Suppl. 1): S3–9PubMedCrossRef
5.
Zurück zum Zitat Daniel R, Smith JA. Integration site selection by retroviral vectors: molecular mechanism and clinical consequences. Hum Gene Ther 2008; 19: 557–68PubMedCrossRef Daniel R, Smith JA. Integration site selection by retroviral vectors: molecular mechanism and clinical consequences. Hum Gene Ther 2008; 19: 557–68PubMedCrossRef
6.
Zurück zum Zitat St George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003; 10: 1135–41PubMedCrossRef St George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003; 10: 1135–41PubMedCrossRef
7.
Zurück zum Zitat Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185–93PubMedCrossRef Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185–93PubMedCrossRef
8.
Zurück zum Zitat Aiuti A, Cattaneo F, Galimberti S, et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009; 360: 447–58PubMedCrossRef Aiuti A, Cattaneo F, Galimberti S, et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009; 360: 447–58PubMedCrossRef
9.
Zurück zum Zitat Hacein-Bey-Abina S, Hauer J, Lim A, et al. Efficacy of gene therapy for Xlinked severe combined immunodeficiency. N Engl J Med 2010; 363: 355–64PubMedCrossRef Hacein-Bey-Abina S, Hauer J, Lim A, et al. Efficacy of gene therapy for Xlinked severe combined immunodeficiency. N Engl J Med 2010; 363: 355–64PubMedCrossRef
10.
Zurück zum Zitat Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A 1988; 85: 6460–4PubMedCrossRef Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A 1988; 85: 6460–4PubMedCrossRef
11.
Zurück zum Zitat Sinn PL, Sauter SL, McCray PBJ. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors — design, biosafety, and production. Gene Ther 2005; 12: 1089–98PubMedCrossRef Sinn PL, Sauter SL, McCray PBJ. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors — design, biosafety, and production. Gene Ther 2005; 12: 1089–98PubMedCrossRef
12.
Zurück zum Zitat Pear WS, Nolan GP, Scott ML, et al. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 1993; 90: 8392–6PubMedCrossRef Pear WS, Nolan GP, Scott ML, et al. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 1993; 90: 8392–6PubMedCrossRef
13.
Zurück zum Zitat Roe T, Reynolds TC, Yu G, et al. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099–108PubMed Roe T, Reynolds TC, Yu G, et al. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099–108PubMed
14.
Zurück zum Zitat Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. 20 years of gene therapy for SCID. Nat Immunol 2010; 11: 457–60PubMedCrossRef Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. 20 years of gene therapy for SCID. Nat Immunol 2010; 11: 457–60PubMedCrossRef
15.
Zurück zum Zitat Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415–9PubMedCrossRef Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415–9PubMedCrossRef
16.
Zurück zum Zitat Howe SJ, Mansour MR, Schwarzwaelder K, et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008; 118: 3143–50PubMedCrossRef Howe SJ, Mansour MR, Schwarzwaelder K, et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008; 118: 3143–50PubMedCrossRef
17.
Zurück zum Zitat Lombardo A, Genovese P, Beausejour CM, et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 2007; 25: 1298–306PubMedCrossRef Lombardo A, Genovese P, Beausejour CM, et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 2007; 25: 1298–306PubMedCrossRef
18.
19.
Zurück zum Zitat Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994; 68: 510–6PubMed Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994; 68: 510–6PubMed
20.
Zurück zum Zitat Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263–7PubMedCrossRef Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263–7PubMedCrossRef
21.
Zurück zum Zitat Vigna E, Naldini L. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2000; 2: 308–16PubMedCrossRef Vigna E, Naldini L. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2000; 2: 308–16PubMedCrossRef
22.
Zurück zum Zitat Maátrai J, Chuah MK, Vanden Driessche T. Recent advances in lentiviral vector development and applications. Mol Ther 2010; 18: 477–90CrossRef Maátrai J, Chuah MK, Vanden Driessche T. Recent advances in lentiviral vector development and applications. Mol Ther 2010; 18: 477–90CrossRef
23.
Zurück zum Zitat Xu K, Ma H, McCown TJ, et al. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther 2001; 3: 97–104PubMedCrossRef Xu K, Ma H, McCown TJ, et al. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther 2001; 3: 97–104PubMedCrossRef
24.
Zurück zum Zitat Thomas S, Stauss HJ, Morris EC. Molecular immunology lessons from therapeutic T-cell receptor gene transfer. Immunology 2010; 129: 170–7PubMedCrossRef Thomas S, Stauss HJ, Morris EC. Molecular immunology lessons from therapeutic T-cell receptor gene transfer. Immunology 2010; 129: 170–7PubMedCrossRef
25.
Zurück zum Zitat Qasim W, Mackey T, Sinclair J, et al. Lentiviral vectors for T-cell suicide gene therapy: preservation of T-cell effector function after cytokine-mediated transduction. Mol Ther 2007; 15: 355–60PubMedCrossRef Qasim W, Mackey T, Sinclair J, et al. Lentiviral vectors for T-cell suicide gene therapy: preservation of T-cell effector function after cytokine-mediated transduction. Mol Ther 2007; 15: 355–60PubMedCrossRef
26.
Zurück zum Zitat Cavalieri S, Cazzaniga S, Geuna M, et al. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 2003; 102: 497–505PubMedCrossRef Cavalieri S, Cazzaniga S, Geuna M, et al. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 2003; 102: 497–505PubMedCrossRef
27.
Zurück zum Zitat Frecha C, Levy C, Cosset FL, et al. Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy. Mol Ther 2010; 18: 1748–57PubMedCrossRef Frecha C, Levy C, Cosset FL, et al. Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy. Mol Ther 2010; 18: 1748–57PubMedCrossRef
28.
Zurück zum Zitat Kaiser J. Gene therapy: beta-thalassemia treatment succeeds, with a caveat. Science 2009; 326: 1468–9PubMedCrossRef Kaiser J. Gene therapy: beta-thalassemia treatment succeeds, with a caveat. Science 2009; 326: 1468–9PubMedCrossRef
29.
Zurück zum Zitat Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009; 326: 818–23PubMedCrossRef Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009; 326: 818–23PubMedCrossRef
30.
31.
Zurück zum Zitat Trobridge G, Josephson N, Vassilopoulos G, et al. Improved foamy virus vectors with minimal viral sequences. Mol Ther 2002; 6: 321–8PubMedCrossRef Trobridge G, Josephson N, Vassilopoulos G, et al. Improved foamy virus vectors with minimal viral sequences. Mol Ther 2002; 6: 321–8PubMedCrossRef
32.
Zurück zum Zitat Erlwein O, McClure MO. Progress and prospects: foamy virus vectors enter a new age. Gene Ther 2010; 17: 1423–9PubMedCrossRef Erlwein O, McClure MO. Progress and prospects: foamy virus vectors enter a new age. Gene Ther 2010; 17: 1423–9PubMedCrossRef
33.
Zurück zum Zitat Trobridge GD. Foamy virus vectors for gene transfer. Expert Opin Biol Ther 2009; 9: 1427–36PubMedCrossRef Trobridge GD. Foamy virus vectors for gene transfer. Expert Opin Biol Ther 2009; 9: 1427–36PubMedCrossRef
34.
Zurück zum Zitat Bauer Jr TR, Allen JM, Hai M, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med 2008; 14: 93–7PubMedCrossRef Bauer Jr TR, Allen JM, Hai M, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med 2008; 14: 93–7PubMedCrossRef
35.
Zurück zum Zitat Si Y, Pulliam AC, Linka Y, et al. Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells. Blood 2008; 112: 4458–65PubMedCrossRef Si Y, Pulliam AC, Linka Y, et al. Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells. Blood 2008; 112: 4458–65PubMedCrossRef
36.
Zurück zum Zitat Rowe WP, Huebner RJ, Gilmore LK, et al. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 1953; 84: 570–3PubMed Rowe WP, Huebner RJ, Gilmore LK, et al. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 1953; 84: 570–3PubMed
37.
Zurück zum Zitat Graham FL, Smiley J, Russell WC, et al. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59–74PubMedCrossRef Graham FL, Smiley J, Russell WC, et al. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59–74PubMedCrossRef
38.
Zurück zum Zitat Arnberg N. Adenovirus receptors: implications for tropism, treatment and targeting. Rev Med Virol 2009; 19: 165–78PubMedCrossRef Arnberg N. Adenovirus receptors: implications for tropism, treatment and targeting. Rev Med Virol 2009; 19: 165–78PubMedCrossRef
39.
Zurück zum Zitat Sharma A, Li X, Bangari DS, et al. Adenovirus receptors and their implications in gene delivery. Virus Res 2009; 143: 184–94PubMedCrossRef Sharma A, Li X, Bangari DS, et al. Adenovirus receptors and their implications in gene delivery. Virus Res 2009; 143: 184–94PubMedCrossRef
40.
41.
Zurück zum Zitat Danthinne X, Imperiale MJ. Production of first generation adenovirus vectors: a review. Gene Ther 2000; 7: 1707–14PubMedCrossRef Danthinne X, Imperiale MJ. Production of first generation adenovirus vectors: a review. Gene Ther 2000; 7: 1707–14PubMedCrossRef
42.
Zurück zum Zitat Nevins JR. Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell 1981; 26: 213–20PubMedCrossRef Nevins JR. Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell 1981; 26: 213–20PubMedCrossRef
43.
Zurück zum Zitat Bett AJ, Haddara W, Prevec L, et al. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A 1994; 91: 8802–6PubMedCrossRef Bett AJ, Haddara W, Prevec L, et al. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A 1994; 91: 8802–6PubMedCrossRef
44.
Zurück zum Zitat Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320–3PubMedCrossRef Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320–3PubMedCrossRef
45.
Zurück zum Zitat Leopold PL, Kreitzer G, Miyazawa N, et al. Dynein- and microtubulemediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther 2000; 11: 151–65PubMedCrossRef Leopold PL, Kreitzer G, Miyazawa N, et al. Dynein- and microtubulemediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther 2000; 11: 151–65PubMedCrossRef
46.
Zurück zum Zitat He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998; 95: 2509–14PubMedCrossRef He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998; 95: 2509–14PubMedCrossRef
47.
Zurück zum Zitat Spergel JM, Chen Kiang S. Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation. Proc Natl Acad Sci U S A 1991; 88: 6472–6PubMedCrossRef Spergel JM, Chen Kiang S. Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation. Proc Natl Acad Sci U S A 1991; 88: 6472–6PubMedCrossRef
48.
Zurück zum Zitat Yang Y, Nunes FA, Berencsi K, et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 1994; 91: 4407–11 Yang Y, Nunes FA, Berencsi K, et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 1994; 91: 4407–11
49.
Zurück zum Zitat Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 2003; 10: 935–40PubMedCrossRef Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 2003; 10: 935–40PubMedCrossRef
50.
Zurück zum Zitat Kochanek S, Schiedner G, Volpers C. High-capacity ‘gutless’ adenoviral vectors. Curr Opin Mol Ther 2001; 3: 454–63PubMed Kochanek S, Schiedner G, Volpers C. High-capacity ‘gutless’ adenoviral vectors. Curr Opin Mol Ther 2001; 3: 454–63PubMed
51.
Zurück zum Zitat Palmer DJ, Ng P. Helper-dependent adenoviral vectors for gene therapy. Hum Gene Ther 2005; 16: 1–16PubMedCrossRef Palmer DJ, Ng P. Helper-dependent adenoviral vectors for gene therapy. Hum Gene Ther 2005; 16: 1–16PubMedCrossRef
52.
Zurück zum Zitat Kim IH, Jozkowicz A, Piedra PA, et al. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A 2001; 98: 13282–7PubMedCrossRef Kim IH, Jozkowicz A, Piedra PA, et al. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A 2001; 98: 13282–7PubMedCrossRef
53.
Zurück zum Zitat Brunetti Pierri N, Palmer DJ, Beaudet AL, et al. Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther 2004; 15: 35–46PubMedCrossRef Brunetti Pierri N, Palmer DJ, Beaudet AL, et al. Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther 2004; 15: 35–46PubMedCrossRef
54.
Zurück zum Zitat Yu W, Fang H. Clinical trials with oncolytic adenovirus in China. Curr Cancer Drug Targets 2007; 7: 141–8PubMedCrossRef Yu W, Fang H. Clinical trials with oncolytic adenovirus in China. Curr Cancer Drug Targets 2007; 7: 141–8PubMedCrossRef
55.
Zurück zum Zitat Nemunaitis J, Khuri F, Ganly I, et al. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol 2001; 19: 289–98PubMed Nemunaitis J, Khuri F, Ganly I, et al. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol 2001; 19: 289–98PubMed
56.
Zurück zum Zitat Atchison RW, Casto BC, Hammon WM. Adenovirus-associated defective virus particles. Science 1965; 149: 754–6PubMedCrossRef Atchison RW, Casto BC, Hammon WM. Adenovirus-associated defective virus particles. Science 1965; 149: 754–6PubMedCrossRef
57.
Zurück zum Zitat Hoggan MD, Blacklow NR, Rowe WP. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A 1966; 55: 1467–74PubMedCrossRef Hoggan MD, Blacklow NR, Rowe WP. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A 1966; 55: 1467–74PubMedCrossRef
58.
Zurück zum Zitat Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 2008; 21: 583–93PubMedCrossRef Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 2008; 21: 583–93PubMedCrossRef
59.
Zurück zum Zitat Hermonat PL, Muzyczka N. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A 1984; 81: 6466–70PubMedCrossRef Hermonat PL, Muzyczka N. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A 1984; 81: 6466–70PubMedCrossRef
60.
Zurück zum Zitat Smith RH. Adeno-associated virus integration: virus versus vector. Gene Ther 2008; 15: 817–22PubMedCrossRef Smith RH. Adeno-associated virus integration: virus versus vector. Gene Ther 2008; 15: 817–22PubMedCrossRef
61.
Zurück zum Zitat Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adenoassociated viruses: normal integration does not require viral gene expression. J Virol 1989; 63: 3822–8PubMed Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adenoassociated viruses: normal integration does not require viral gene expression. J Virol 1989; 63: 3822–8PubMed
62.
Zurück zum Zitat Grimm D, Kern A, Rittner K, et al. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther 1998; 9: 2745–60PubMedCrossRef Grimm D, Kern A, Rittner K, et al. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther 1998; 9: 2745–60PubMedCrossRef
63.
Zurück zum Zitat Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adenoassociated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224–32 Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adenoassociated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224–32
64.
Zurück zum Zitat Kay MA, Manno CS, Ragni MV, et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257–61PubMedCrossRef Kay MA, Manno CS, Ragni MV, et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257–61PubMedCrossRef
65.
Zurück zum Zitat Manno CS, Chew AJ, Hutchison S, et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003; 101: 2963–72PubMedCrossRef Manno CS, Chew AJ, Hutchison S, et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003; 101: 2963–72PubMedCrossRef
66.
Zurück zum Zitat Manno CS, Pierce GF, Arruda VR, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006; 12: 342–7PubMedCrossRef Manno CS, Pierce GF, Arruda VR, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006; 12: 342–7PubMedCrossRef
67.
Zurück zum Zitat Epstein AL. Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors. Gene Ther 2009; 16: 709–15PubMedCrossRef Epstein AL. Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors. Gene Ther 2009; 16: 709–15PubMedCrossRef
68.
Zurück zum Zitat Manservigi R, Argnani R, Marconi P. HSV recombinant vectors for gene therapy. Open Virol J 2010; 4: 123–56PubMed Manservigi R, Argnani R, Marconi P. HSV recombinant vectors for gene therapy. Open Virol J 2010; 4: 123–56PubMed
69.
Zurück zum Zitat Burton EA, Bai Q, Goins WF, et al. Replication-defective genomic herpes simplex vectors: design and production. Curr Opin Biotechnol 2002; 13: 424–8PubMedCrossRef Burton EA, Bai Q, Goins WF, et al. Replication-defective genomic herpes simplex vectors: design and production. Curr Opin Biotechnol 2002; 13: 424–8PubMedCrossRef
70.
Zurück zum Zitat Friedman GK, Pressey JG, Reddy AT, et al. Herpes simplex virus oncolytic therapy for pediatric malignancies. Mol Ther 2009; 17: 1125–35PubMedCrossRef Friedman GK, Pressey JG, Reddy AT, et al. Herpes simplex virus oncolytic therapy for pediatric malignancies. Mol Ther 2009; 17: 1125–35PubMedCrossRef
71.
Zurück zum Zitat Shah AC, Benos D, Gillespie GY, et al. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. J Neurooncol 2003; 65: 203–26PubMedCrossRef Shah AC, Benos D, Gillespie GY, et al. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. J Neurooncol 2003; 65: 203–26PubMedCrossRef
72.
Zurück zum Zitat Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in the treatment of chronic pain. Mol Ther 2009; 17: 13–8PubMedCrossRef Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in the treatment of chronic pain. Mol Ther 2009; 17: 13–8PubMedCrossRef
73.
Zurück zum Zitat Goss JR, Gold MS, Glorioso JC. HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain. Gene Ther 2009; 16: 493–501PubMedCrossRef Goss JR, Gold MS, Glorioso JC. HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain. Gene Ther 2009; 16: 493–501PubMedCrossRef
74.
Zurück zum Zitat Lieber A, Steinwaerder DS, Carlson CA, et al. Integrating adenovirus-adenoassociated virus hybrid vectors devoid of all viral genes. J Virol 1999; 73: 9314–24PubMed Lieber A, Steinwaerder DS, Carlson CA, et al. Integrating adenovirus-adenoassociated virus hybrid vectors devoid of all viral genes. J Virol 1999; 73: 9314–24PubMed
75.
Zurück zum Zitat Recchia A, Parks RJ, Lamartina S, et al. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc Natl Acad Sci U S A 1999; 96: 2615–20PubMedCrossRef Recchia A, Parks RJ, Lamartina S, et al. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc Natl Acad Sci U S A 1999; 96: 2615–20PubMedCrossRef
76.
Zurück zum Zitat Oehmig A, Fraefel C, Breakefield XO, et al. Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus. Curr Gene Ther 2004; 4: 385–408PubMedCrossRef Oehmig A, Fraefel C, Breakefield XO, et al. Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus. Curr Gene Ther 2004; 4: 385–408PubMedCrossRef
77.
Zurück zum Zitat Fisher KD, Stallwood Y, Green NK, et al. Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther 2001; 8: 341–8PubMedCrossRef Fisher KD, Stallwood Y, Green NK, et al. Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther 2001; 8: 341–8PubMedCrossRef
78.
Zurück zum Zitat Avery OT, MacLeod CM, McCarty M. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: inductions of transformation by a deoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 1979; 149: 297–326PubMedCrossRef Avery OT, MacLeod CM, McCarty M. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: inductions of transformation by a deoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 1979; 149: 297–326PubMedCrossRef
79.
Zurück zum Zitat Graham FL, van der Eb AJ. Transformation of rat cells by DNA of human adenovirus 5. Virology 1973; 54: 536–9PubMedCrossRef Graham FL, van der Eb AJ. Transformation of rat cells by DNA of human adenovirus 5. Virology 1973; 54: 536–9PubMedCrossRef
80.
Zurück zum Zitat Pathak A, Patnaik S, Gupta Kailash C. Recent trends in non-viral vectormediated gene delivery. Biotechnol J 2009; 4: 1559–72 81._Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009; 109: 259–302 82._Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238–52PubMedCrossRef Pathak A, Patnaik S, Gupta Kailash C. Recent trends in non-viral vectormediated gene delivery. Biotechnol J 2009; 4: 1559–72 81._Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009; 109: 259–302 82._Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238–52PubMedCrossRef
81.
82.
Zurück zum Zitat Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238–52PubMedCrossRef Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238–52PubMedCrossRef
83.
Zurück zum Zitat Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipidmediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987; 84: 7413–7 Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipidmediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987; 84: 7413–7
84.
Zurück zum Zitat Simoes S, Filipe A, Faneca H, et al. Cationic liposomes for gene delivery. Expert Opin Drug Deliv 2005; 2: 237–54PubMedCrossRef Simoes S, Filipe A, Faneca H, et al. Cationic liposomes for gene delivery. Expert Opin Drug Deliv 2005; 2: 237–54PubMedCrossRef
85.
86.
Zurück zum Zitat Montier T, Benvegnu T, Jaffres PA, et al. Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example. Curr Gene Ther 2008; 8: 296–312PubMedCrossRef Montier T, Benvegnu T, Jaffres PA, et al. Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example. Curr Gene Ther 2008; 8: 296–312PubMedCrossRef
87.
Zurück zum Zitat Zhou X, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim Biophys Acta 1994; 1189: 195–203PubMedCrossRef Zhou X, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim Biophys Acta 1994; 1189: 195–203PubMedCrossRef
88.
Zurück zum Zitat Xu L, Huang CC, Huang W, et al. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 2002; 1: 337–46PubMedCrossRef Xu L, Huang CC, Huang W, et al. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 2002; 1: 337–46PubMedCrossRef
89.
Zurück zum Zitat Pardridge WM. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug Chem 2008; 19: 1327–38PubMedCrossRef Pardridge WM. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug Chem 2008; 19: 1327–38PubMedCrossRef
90.
Zurück zum Zitat Durcan N, Murphy C, Cryan SA. Inhalable siRNA: potential as a therapeutic agent in the lungs. Mol Pharm 2008; 5: 559–66PubMedCrossRef Durcan N, Murphy C, Cryan SA. Inhalable siRNA: potential as a therapeutic agent in the lungs. Mol Pharm 2008; 5: 559–66PubMedCrossRef
91.
Zurück zum Zitat Stopeck AT, Hersh EM, Akporiaye ET, et al. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma. J Clin Oncol 1997; 15: 341–9PubMed Stopeck AT, Hersh EM, Akporiaye ET, et al. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma. J Clin Oncol 1997; 15: 341–9PubMed
92.
Zurück zum Zitat Stopeck AT, Jones A, Hersh EM, et al. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNAliposome complex, in patients with metastatic melanoma. Clin Cancer Res 2001; 7: 2285–91PubMed Stopeck AT, Jones A, Hersh EM, et al. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNAliposome complex, in patients with metastatic melanoma. Clin Cancer Res 2001; 7: 2285–91PubMed
93.
Zurück zum Zitat Boussif O, Lezoualc’h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995; 92: 7297–301PubMedCrossRef Boussif O, Lezoualc’h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995; 92: 7297–301PubMedCrossRef
94.
Zurück zum Zitat Goula D, Remy JS, Erbacher P, et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 1998; 5: 712–7PubMedCrossRef Goula D, Remy JS, Erbacher P, et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 1998; 5: 712–7PubMedCrossRef
95.
Zurück zum Zitat Chemin I, Moradpour D, Wieland S, et al. Liver-directed gene transfer: a linear polyethlenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo. J Viral Hepat 1998; 5: 369–75PubMedCrossRef Chemin I, Moradpour D, Wieland S, et al. Liver-directed gene transfer: a linear polyethlenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo. J Viral Hepat 1998; 5: 369–75PubMedCrossRef
96.
Zurück zum Zitat Haensler J, Szoka FC J. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem 1993; 4: 372–9PubMedCrossRef Haensler J, Szoka FC J. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem 1993; 4: 372–9PubMedCrossRef
97.
Zurück zum Zitat Tang MX, Redemann CT, Szoka FC J. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem 1996; 7: 703–14PubMedCrossRef Tang MX, Redemann CT, Szoka FC J. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem 1996; 7: 703–14PubMedCrossRef
98.
Zurück zum Zitat Rudolph C, Lausier J, Naundorf S, et al. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J Gene Med 2000; 2: 269–78PubMedCrossRef Rudolph C, Lausier J, Naundorf S, et al. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J Gene Med 2000; 2: 269–78PubMedCrossRef
99.
Zurück zum Zitat Nimesh S, Kumar R, Chandra R. Novel polyallylamine-dextran sulfate-DNA nanoplexes: highly efficient non-viral vector for gene delivery. Int J Pharm 2006; 320: 143–9PubMedCrossRef Nimesh S, Kumar R, Chandra R. Novel polyallylamine-dextran sulfate-DNA nanoplexes: highly efficient non-viral vector for gene delivery. Int J Pharm 2006; 320: 143–9PubMedCrossRef
100.
Zurück zum Zitat Erbacher P, Zou S, Bettinger T, et al. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res 1998; 15: 1332–9PubMedCrossRef Erbacher P, Zou S, Bettinger T, et al. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res 1998; 15: 1332–9PubMedCrossRef
101.
Zurück zum Zitat Schatzlein AG, Zinselmeyer BH, Elouzi A, et al. Preferential liver gene expression with polypropylenimine dendrimers. J Control Release 2005; 101: 247–58PubMedCrossRef Schatzlein AG, Zinselmeyer BH, Elouzi A, et al. Preferential liver gene expression with polypropylenimine dendrimers. J Control Release 2005; 101: 247–58PubMedCrossRef
102.
Zurück zum Zitat Balicki D, Beutler E. Histone H2A significantly enhances in vitro DNA transfection. Mol Med 1997; 3: 782–7PubMed Balicki D, Beutler E. Histone H2A significantly enhances in vitro DNA transfection. Mol Med 1997; 3: 782–7PubMed
103.
Zurück zum Zitat Balicki D, Putnam CD, Scaria PV, et al. Structure and function correlation in histoneH2A peptide-mediated gene transfer. Proc Natl Acad Sci U S A 2002; 99: 7467–71PubMedCrossRef Balicki D, Putnam CD, Scaria PV, et al. Structure and function correlation in histoneH2A peptide-mediated gene transfer. Proc Natl Acad Sci U S A 2002; 99: 7467–71PubMedCrossRef
104.
Zurück zum Zitat Sweeney P, Karashima T, Ishikura H, et al. Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model. Cancer Res 2003; 63: 4017–20PubMed Sweeney P, Karashima T, Ishikura H, et al. Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model. Cancer Res 2003; 63: 4017–20PubMed
105.
Zurück zum Zitat Konstan MW, Davis PB, Wagener JS, et al. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther 2004; 15: 1255–69PubMedCrossRef Konstan MW, Davis PB, Wagener JS, et al. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther 2004; 15: 1255–69PubMedCrossRef
106.
Zurück zum Zitat Avrameas A, Ternynck T, Nato F, et al. Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proc Natl Acad Sci U S A 1998; 95: 5601–6PubMedCrossRef Avrameas A, Ternynck T, Nato F, et al. Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proc Natl Acad Sci U S A 1998; 95: 5601–6PubMedCrossRef
107.
Zurück zum Zitat Lee RJ, Huang L. Folate-targeted, anionic liposome-entrapped polylysinecondensedDNAfor tumor cell-specific gene transfer. J Biol Chem 1996; 271: 8481–7PubMedCrossRef Lee RJ, Huang L. Folate-targeted, anionic liposome-entrapped polylysinecondensedDNAfor tumor cell-specific gene transfer. J Biol Chem 1996; 271: 8481–7PubMedCrossRef
108.
Zurück zum Zitat Sorgi FL, Bhattacharya S, Huang L. Protamine sulfate enhances lipidmediated gene transfer. Gene Ther 1997; 4: 961–8PubMedCrossRef Sorgi FL, Bhattacharya S, Huang L. Protamine sulfate enhances lipidmediated gene transfer. Gene Ther 1997; 4: 961–8PubMedCrossRef
109.
Zurück zum Zitat Lee LK, Williams CL, Devore D, et al. Poly(propylacrylic acid) enhances cationic lipid-mediated delivery of antisense oligonucleotides. Biomacromolecules 2006; 7: 1502–8PubMedCrossRef Lee LK, Williams CL, Devore D, et al. Poly(propylacrylic acid) enhances cationic lipid-mediated delivery of antisense oligonucleotides. Biomacromolecules 2006; 7: 1502–8PubMedCrossRef
110.
Zurück zum Zitat Murphy EA, Waring AJ, Haynes SM, et al. Compaction of DNA in an anionic micelle environment followed by assembly into phosphatidylcholine liposomes. Nucleic Acids Res 2000; 28: 2986–92PubMedCrossRef Murphy EA, Waring AJ, Haynes SM, et al. Compaction of DNA in an anionic micelle environment followed by assembly into phosphatidylcholine liposomes. Nucleic Acids Res 2000; 28: 2986–92PubMedCrossRef
111.
Zurück zum Zitat Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 1997; 4: 891–900PubMedCrossRef Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 1997; 4: 891–900PubMedCrossRef
112.
Zurück zum Zitat Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465–8PubMedCrossRef Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465–8PubMedCrossRef
113.
Zurück zum Zitat Choate KA, Khavari PA. Direct cutaneous gene delivery in a human genetic skin disease. Hum Gene Ther 1997; 8: 1659–65PubMedCrossRef Choate KA, Khavari PA. Direct cutaneous gene delivery in a human genetic skin disease. Hum Gene Ther 1997; 8: 1659–65PubMedCrossRef
114.
Zurück zum Zitat Park SW, Gwon HC, Jeong JO, et al. Intracardiac echocardiographic guidance and monitoring during percutaneous endomyocardial gene injection in porcine heart. Hum Gene Ther 2001; 12: 893–903PubMedCrossRef Park SW, Gwon HC, Jeong JO, et al. Intracardiac echocardiographic guidance and monitoring during percutaneous endomyocardial gene injection in porcine heart. Hum Gene Ther 2001; 12: 893–903PubMedCrossRef
115.
Zurück zum Zitat Hickman MA, Malone RW, Lehmann-Bruinsma K, et al. Gene expression following direct injection of DNA into liver. Hum Gene Ther 1994; 5: 1477–83PubMedCrossRef Hickman MA, Malone RW, Lehmann-Bruinsma K, et al. Gene expression following direct injection of DNA into liver. Hum Gene Ther 1994; 5: 1477–83PubMedCrossRef
116.
Zurück zum Zitat Habib NA, Ding SF, el-Masry R, et al. Preliminary report: the short-term effects of direct p53 DNA injection in primary hepatocellular carcinomas. Cancer Detect Prev 1996; 20: 103–7PubMed Habib NA, Ding SF, el-Masry R, et al. Preliminary report: the short-term effects of direct p53 DNA injection in primary hepatocellular carcinomas. Cancer Detect Prev 1996; 20: 103–7PubMed
117.
Zurück zum Zitat Prausnitz MR, Mikszta JA, Cormier M, et al. Microneedle-based vaccines. Curr Top Microbiol Immunol 2009; 333: 369–93PubMedCrossRef Prausnitz MR, Mikszta JA, Cormier M, et al. Microneedle-based vaccines. Curr Top Microbiol Immunol 2009; 333: 369–93PubMedCrossRef
118.
Zurück zum Zitat Hartikka J, Sawdey M, Cornefert Jensen F, et al. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 1996; 7: 1205–17PubMedCrossRef Hartikka J, Sawdey M, Cornefert Jensen F, et al. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 1996; 7: 1205–17PubMedCrossRef
119.
Zurück zum Zitat Klein RM, Wolf ED, Wu R, et al. High-velocity microprojectiles for delivering nucleic acids into living cells: 1987. Biotechnology 1992; 24: 384–6PubMed Klein RM, Wolf ED, Wu R, et al. High-velocity microprojectiles for delivering nucleic acids into living cells: 1987. Biotechnology 1992; 24: 384–6PubMed
120.
Zurück zum Zitat O’Brien J, Lummis SC. An improved method of preparing microcarriers for biolistic transfection. Brain Res Brain Res Protoc 2002; 10: 12–5PubMedCrossRef O’Brien J, Lummis SC. An improved method of preparing microcarriers for biolistic transfection. Brain Res Brain Res Protoc 2002; 10: 12–5PubMedCrossRef
121.
Zurück zum Zitat Yang NS, Burkholder J, Roberts B, et al. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A 1990; 87: 9568–72PubMedCrossRef Yang NS, Burkholder J, Roberts B, et al. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A 1990; 87: 9568–72PubMedCrossRef
122.
Zurück zum Zitat Wang S, Joshi S, Lu S. Delivery of DNA to skin by particle bombardment. Methods Mol Biol 2004; 245: 185–96PubMed Wang S, Joshi S, Lu S. Delivery of DNA to skin by particle bombardment. Methods Mol Biol 2004; 245: 185–96PubMed
123.
Zurück zum Zitat Kim D, Hoory T, Monie A, et al. Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun. J Immunol 2008; 180: 7019–27PubMed Kim D, Hoory T, Monie A, et al. Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun. J Immunol 2008; 180: 7019–27PubMed
124.
Zurück zum Zitat Roberts LK, Barr LJ, Fuller DH, et al. Clinical safety and efficacy of a powdered hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine 2005; 23: 4867–78PubMedCrossRef Roberts LK, Barr LJ, Fuller DH, et al. Clinical safety and efficacy of a powdered hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine 2005; 23: 4867–78PubMedCrossRef
125.
Zurück zum Zitat Drape RJ, Macklin MD, Barr LJ, et al. Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine 2006; 24: 4475–81PubMedCrossRef Drape RJ, Macklin MD, Barr LJ, et al. Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine 2006; 24: 4475–81PubMedCrossRef
126.
Zurück zum Zitat Cassaday RD, Sondel PM, King DM, et al. A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients. Clin Cancer Res 2007; 13: 540–9PubMedCrossRef Cassaday RD, Sondel PM, King DM, et al. A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients. Clin Cancer Res 2007; 13: 540–9PubMedCrossRef
127.
Zurück zum Zitat Yager EJ, Dean HJ, Fuller DH. Prospects for developing an effective particlemediated DNA vaccine against influenza. Expert Rev Vaccines 2009; 8: 1205–20PubMedCrossRef Yager EJ, Dean HJ, Fuller DH. Prospects for developing an effective particlemediated DNA vaccine against influenza. Expert Rev Vaccines 2009; 8: 1205–20PubMedCrossRef
128.
Zurück zum Zitat Kaur T, Slavcev RA, Wettig SD. Addressing the challenge: current and future directions in ovarian cancer therapy. Curr Gene Ther 2009; 9: 434–58PubMedCrossRef Kaur T, Slavcev RA, Wettig SD. Addressing the challenge: current and future directions in ovarian cancer therapy. Curr Gene Ther 2009; 9: 434–58PubMedCrossRef
129.
Zurück zum Zitat Neumann E, Schaefer-Ridder M, Wang Y, et al. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1: 841–5PubMed Neumann E, Schaefer-Ridder M, Wang Y, et al. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1: 841–5PubMed
130.
Zurück zum Zitat Favard C, Dean DS, RolsM-P. Electrotransfer as a nonviral method of gene delivery. Curr Gene Ther 2007; 7: 67–77PubMedCrossRef Favard C, Dean DS, RolsM-P. Electrotransfer as a nonviral method of gene delivery. Curr Gene Ther 2007; 7: 67–77PubMedCrossRef
131.
Zurück zum Zitat Heller LC, Ugen K, Heller R. Electroporation for targeted gene transfer. Expert Opin Drug Deliv 2005; 2: 255–68PubMedCrossRef Heller LC, Ugen K, Heller R. Electroporation for targeted gene transfer. Expert Opin Drug Deliv 2005; 2: 255–68PubMedCrossRef
132.
Zurück zum Zitat van Drunen Littel-van den Hurk S, Hannaman D. Electroporation for DNA immunization: clinical application. Expert Rev Vaccines 2010; 9: 503–17CrossRef van Drunen Littel-van den Hurk S, Hannaman D. Electroporation for DNA immunization: clinical application. Expert Rev Vaccines 2010; 9: 503–17CrossRef
133.
Zurück zum Zitat Wells DJ. Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 2004; 11: 1363–9PubMedCrossRef Wells DJ. Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 2004; 11: 1363–9PubMedCrossRef
134.
Zurück zum Zitat Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77: 964–71PubMedCrossRef Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77: 964–71PubMedCrossRef
135.
Zurück zum Zitat Bodles-Brakhop AM, Heller R, Draghia-Akli R. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol Ther 2009; 17: 585–92PubMedCrossRef Bodles-Brakhop AM, Heller R, Draghia-Akli R. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol Ther 2009; 17: 585–92PubMedCrossRef
136.
Zurück zum Zitat Kim HJ, Greenleaf JF, Kinnick RR, et al. Ultrasound-mediated transfection of mammalian cells. Hum Gene Ther 1996; 7: 1339–46PubMedCrossRef Kim HJ, Greenleaf JF, Kinnick RR, et al. Ultrasound-mediated transfection of mammalian cells. Hum Gene Ther 1996; 7: 1339–46PubMedCrossRef
137.
Zurück zum Zitat Tata DB, Dunn F, Tindall DJ. Selective clinical ultrasound signals mediate differential gene transfer and expression in two human prostate cancer cell lines: LnCap and PC-3. Biochem Biophys Res Commun 1997; 234: 64–7PubMedCrossRef Tata DB, Dunn F, Tindall DJ. Selective clinical ultrasound signals mediate differential gene transfer and expression in two human prostate cancer cell lines: LnCap and PC-3. Biochem Biophys Res Commun 1997; 234: 64–7PubMedCrossRef
138.
Zurück zum Zitat Bao S, Thrall BD, Gies RA, et al. In vivo transfection of melanoma cells by lithotripter shock waves. Cancer Res 1998; 58: 219–21PubMed Bao S, Thrall BD, Gies RA, et al. In vivo transfection of melanoma cells by lithotripter shock waves. Cancer Res 1998; 58: 219–21PubMed
139.
Zurück zum Zitat Huber PE, Jenne J, Debus J, et al. Acomparison of shockwave and sinusoidalfocused ultrasound-induced localized transfection of HeLa cells. Ultrasound Med Biol 1999; 25: 1451–7PubMedCrossRef Huber PE, Jenne J, Debus J, et al. Acomparison of shockwave and sinusoidalfocused ultrasound-induced localized transfection of HeLa cells. Ultrasound Med Biol 1999; 25: 1451–7PubMedCrossRef
140.
Zurück zum Zitat Sonoda S, Tachibana K, Uchino E, et al. Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. Invest Ophthalmol Vis Sci 2006; 47: 558–64PubMedCrossRef Sonoda S, Tachibana K, Uchino E, et al. Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. Invest Ophthalmol Vis Sci 2006; 47: 558–64PubMedCrossRef
141.
Zurück zum Zitat Hynynen K, McDannold N, Martin H, et al. The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison). Ultrasound Med Biol 2003; 29: 473–81PubMedCrossRef Hynynen K, McDannold N, Martin H, et al. The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison). Ultrasound Med Biol 2003; 29: 473–81PubMedCrossRef
142.
Zurück zum Zitat Manome Y, Nakayama N, Nakayama K, et al. Insonation facilitates plasmid DNA transfection into the central nervous system and microbubbles enhance the effect. Ultrasound Med Biol 2005; 31: 693–702PubMedCrossRef Manome Y, Nakayama N, Nakayama K, et al. Insonation facilitates plasmid DNA transfection into the central nervous system and microbubbles enhance the effect. Ultrasound Med Biol 2005; 31: 693–702PubMedCrossRef
143.
Zurück zum Zitat Shimamura M, Sato N, Taniyama Y, et al. Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubbleenhanced ultrasound. Gene Ther 2004; 11: 1532–9PubMedCrossRef Shimamura M, Sato N, Taniyama Y, et al. Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubbleenhanced ultrasound. Gene Ther 2004; 11: 1532–9PubMedCrossRef
144.
Zurück zum Zitat Shimamura M, Sato N, Taniyama Y, et al. Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles. J Gene Med 2005; 7: 1468–74PubMedCrossRef Shimamura M, Sato N, Taniyama Y, et al. Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles. J Gene Med 2005; 7: 1468–74PubMedCrossRef
145.
Zurück zum Zitat Sheyn D, Kimelman-Bleich N, Pelled G, et al. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther 2007; 15: 257–66PubMedCrossRef Sheyn D, Kimelman-Bleich N, Pelled G, et al. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther 2007; 15: 257–66PubMedCrossRef
146.
Zurück zum Zitat Guo H, Leung JCK, Chan LYY, et al. Ultrasound-contrast agent mediated naked gene delivery in the peritoneal cavity of adult rat. Gene Ther 2007; 14: 1712–20PubMedCrossRef Guo H, Leung JCK, Chan LYY, et al. Ultrasound-contrast agent mediated naked gene delivery in the peritoneal cavity of adult rat. Gene Ther 2007; 14: 1712–20PubMedCrossRef
147.
Zurück zum Zitat Hou C-C, Wang W, Huang XR, et al. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am J Pathol 2005; 166: 761–71PubMedCrossRef Hou C-C, Wang W, Huang XR, et al. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am J Pathol 2005; 166: 761–71PubMedCrossRef
148.
Zurück zum Zitat Chen S, Ding J-H, Bekeredjian R, et al. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A 2006; 103: 8469–74PubMedCrossRef Chen S, Ding J-H, Bekeredjian R, et al. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A 2006; 103: 8469–74PubMedCrossRef
149.
Zurück zum Zitat Shen ZP, Brayman AA, Chen L, et al. Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery. Gene Ther 2008; 15: 1147–55PubMedCrossRef Shen ZP, Brayman AA, Chen L, et al. Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery. Gene Ther 2008; 15: 1147–55PubMedCrossRef
150.
Zurück zum Zitat Miao CH, Brayman AA, Loeb KR, et al. Ultrasound enhances gene delivery of human factor IX plasmid. Hum Gene Ther 2005; 16: 893–905PubMedCrossRef Miao CH, Brayman AA, Loeb KR, et al. Ultrasound enhances gene delivery of human factor IX plasmid. Hum Gene Ther 2005; 16: 893–905PubMedCrossRef
151.
Zurück zum Zitat Ohta S, Suzuki K, Tachibana K, et al. Microbubble-enhanced sonoporation: efficient gene transduction technique for chick embryos. Genesis 2003; 37: 91–101PubMedCrossRef Ohta S, Suzuki K, Tachibana K, et al. Microbubble-enhanced sonoporation: efficient gene transduction technique for chick embryos. Genesis 2003; 37: 91–101PubMedCrossRef
152.
Zurück zum Zitat Nakashima M, Tachibana K, Iohara K, et al. Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/differentiation factor 11. Hum Gene Ther 2003; 14: 591–7PubMedCrossRef Nakashima M, Tachibana K, Iohara K, et al. Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/differentiation factor 11. Hum Gene Ther 2003; 14: 591–7PubMedCrossRef
153.
Zurück zum Zitat Taniyama Y, Tachibana K, Hiraoka K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmidDNAin skeletal muscle. Gene Ther 2002; 9: 372–80PubMedCrossRef Taniyama Y, Tachibana K, Hiraoka K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmidDNAin skeletal muscle. Gene Ther 2002; 9: 372–80PubMedCrossRef
154.
Zurück zum Zitat Lu QL, Liang H-D, Partridge T, et al. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther 2003; 10: 396–405PubMedCrossRef Lu QL, Liang H-D, Partridge T, et al. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther 2003; 10: 396–405PubMedCrossRef
155.
Zurück zum Zitat Bekeredjian R, Chen S, Frenkel PA, et al. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003; 108: 1022–6PubMedCrossRef Bekeredjian R, Chen S, Frenkel PA, et al. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003; 108: 1022–6PubMedCrossRef
156.
Zurück zum Zitat Bekeredjian R, Grayburn PA, Shohet RV. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 2005; 45: 329–35PubMedCrossRef Bekeredjian R, Grayburn PA, Shohet RV. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 2005; 45: 329–35PubMedCrossRef
157.
Zurück zum Zitat Suzuki R, Takizawa T, Negishi Y, et al. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J Control Release 2008; 125: 137–44PubMedCrossRef Suzuki R, Takizawa T, Negishi Y, et al. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J Control Release 2008; 125: 137–44PubMedCrossRef
158.
Zurück zum Zitat Hayashi S, Mizuno M, Yoshida J, et al. Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer. Cancer Gene Ther 2009; 16: 638–43PubMedCrossRef Hayashi S, Mizuno M, Yoshida J, et al. Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer. Cancer Gene Ther 2009; 16: 638–43PubMedCrossRef
159.
Zurück zum Zitat Suzuki R, Namai E, Oda Y, et al. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J Control Release 2010; 142: 245–50PubMedCrossRef Suzuki R, Namai E, Oda Y, et al. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J Control Release 2010; 142: 245–50PubMedCrossRef
160.
Zurück zum Zitat Barreiro O, Aguilar Rio J, Tejera E, et al. Specific targeting of human inflamed endothelium and in situ vascular tissue transfection by the use of ultrasound contrast agents. JACC Cardiovasc Imaging 2009; 2: 997–1005PubMedCrossRef Barreiro O, Aguilar Rio J, Tejera E, et al. Specific targeting of human inflamed endothelium and in situ vascular tissue transfection by the use of ultrasound contrast agents. JACC Cardiovasc Imaging 2009; 2: 997–1005PubMedCrossRef
161.
Zurück zum Zitat Kodama T, Aoi A, Watanabe Y, et al. Evaluation of transfection efficiency in skeletal muscle using nano/microbubbles and ultrasound. Ultrasound Med Biol 2010; 36: 1196–205PubMedCrossRef Kodama T, Aoi A, Watanabe Y, et al. Evaluation of transfection efficiency in skeletal muscle using nano/microbubbles and ultrasound. Ultrasound Med Biol 2010; 36: 1196–205PubMedCrossRef
162.
Zurück zum Zitat Zeira E, Manevitch A, Khatchatouriants A, et al. Femtosecond infrared laseran efficient and safe in vivo gene delivery system for prolonged expression. Mol Ther 2003; 8: 342–50PubMedCrossRef Zeira E, Manevitch A, Khatchatouriants A, et al. Femtosecond infrared laseran efficient and safe in vivo gene delivery system for prolonged expression. Mol Ther 2003; 8: 342–50PubMedCrossRef
163.
Zurück zum Zitat Chakravarty P, Qian W, El-Sayed MA, et al. Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses. Nat Nanotechnol 2010; 5: 607–11PubMedCrossRef Chakravarty P, Qian W, El-Sayed MA, et al. Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses. Nat Nanotechnol 2010; 5: 607–11PubMedCrossRef
164.
Zurück zum Zitat Plank C, Anton M, Rudolph C, et al. Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opin Biol Ther 2003; 3: 745–58PubMedCrossRef Plank C, Anton M, Rudolph C, et al. Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opin Biol Ther 2003; 3: 745–58PubMedCrossRef
165.
Zurück zum Zitat Dobson J. Gene therapy progress and prospects:magnetic nanoparticle-based gene delivery. Gene Ther 2006; 13: 283–7PubMedCrossRef Dobson J. Gene therapy progress and prospects:magnetic nanoparticle-based gene delivery. Gene Ther 2006; 13: 283–7PubMedCrossRef
166.
Zurück zum Zitat Mykhaylyk O, Antequera YS, Vlaskou D, et al. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc 2007; 2: 2391–411PubMedCrossRef Mykhaylyk O, Antequera YS, Vlaskou D, et al. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc 2007; 2: 2391–411PubMedCrossRef
167.
Zurück zum Zitat Scherer F, Anton M, Schillinger U, et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 2002; 9: 102–9PubMedCrossRef Scherer F, Anton M, Schillinger U, et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 2002; 9: 102–9PubMedCrossRef
168.
Zurück zum Zitat Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258–66PubMedCrossRef Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258–66PubMedCrossRef
169.
Zurück zum Zitat Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735–7PubMedCrossRef Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735–7PubMedCrossRef
170.
Zurück zum Zitat Zhang G, Gao X, Song YK, et al. Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther 2004; 11: 675–82PubMedCrossRef Zhang G, Gao X, Song YK, et al. Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther 2004; 11: 675–82PubMedCrossRef
171.
Zurück zum Zitat Suda T, Liu D. Hydrodynamic gene delivery: its principles and applications. Mol Ther 2007; 15: 2063–9PubMedCrossRef Suda T, Liu D. Hydrodynamic gene delivery: its principles and applications. Mol Ther 2007; 15: 2063–9PubMedCrossRef
172.
Zurück zum Zitat Brunetti-Pierri N, Stapleton GE, Palmer DJ, et al. Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol Ther 2007; 15: 732–40PubMed Brunetti-Pierri N, Stapleton GE, Palmer DJ, et al. Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol Ther 2007; 15: 732–40PubMed
173.
Zurück zum Zitat Brunetti-Pierri N, Palmer DJ, Mane V, et al. Increased hepatic transduction with reduced systemic dissemination and proinflammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors. Mol Ther 2005; 12: 99–106PubMedCrossRef Brunetti-Pierri N, Palmer DJ, Mane V, et al. Increased hepatic transduction with reduced systemic dissemination and proinflammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors. Mol Ther 2005; 12: 99–106PubMedCrossRef
174.
Zurück zum Zitat Condiotti R, Curran MA, Nolan GP, et al. Prolonged liver-specific transgene expression by a non-primate lentiviral vector. Biochem Biophys Res Commun 2004; 320: 998–1006PubMedCrossRef Condiotti R, Curran MA, Nolan GP, et al. Prolonged liver-specific transgene expression by a non-primate lentiviral vector. Biochem Biophys Res Commun 2004; 320: 998–1006PubMedCrossRef
175.
Zurück zum Zitat Arad U, Zeira E, El-Latif MA, et al. Liver-targeted gene therapy by SV40- based vectors using the hydrodynamic injection method. Hum Gene Ther 2005; 16: 361–71PubMedCrossRef Arad U, Zeira E, El-Latif MA, et al. Liver-targeted gene therapy by SV40- based vectors using the hydrodynamic injection method. Hum Gene Ther 2005; 16: 361–71PubMedCrossRef
176.
Zurück zum Zitat Herweijer H, Wolff JA. Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther 2007; 14: 99–107PubMed Herweijer H, Wolff JA. Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther 2007; 14: 99–107PubMed
177.
Zurück zum Zitat Qiao C, Li J, Zheng H, et al. Hydrodynamic limb vein injection of adenoassociated virus serotype 8 vector carrying caninemyostatin propeptide gene into normal dogs enhances muscle growth. Hum Gene Ther 2009; 20: 1–10PubMedCrossRef Qiao C, Li J, Zheng H, et al. Hydrodynamic limb vein injection of adenoassociated virus serotype 8 vector carrying caninemyostatin propeptide gene into normal dogs enhances muscle growth. Hum Gene Ther 2009; 20: 1–10PubMedCrossRef
178.
Zurück zum Zitat Chen L, Zhu F, Li J, et al. The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol Ther 2007; 15: 1856–62PubMedCrossRef Chen L, Zhu F, Li J, et al. The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol Ther 2007; 15: 1856–62PubMedCrossRef
179.
Zurück zum Zitat Doenecke A, Kromer A, Scherer MN, et al. AAV plasmid DNA simplifies liver-directed in vivo gene therapy: comparison of expression levels after plasmid DNA-, adeno-associated virus- and adenovirus-mediated liver transfection. J Gene Med 2010; 12: 810–7PubMedCrossRef Doenecke A, Kromer A, Scherer MN, et al. AAV plasmid DNA simplifies liver-directed in vivo gene therapy: comparison of expression levels after plasmid DNA-, adeno-associated virus- and adenovirus-mediated liver transfection. J Gene Med 2010; 12: 810–7PubMedCrossRef
180.
Zurück zum Zitat Suda T, Kamimura K, Kubota T, et al. Progress toward liver-based gene therapy. Hepatol Res 2009; 39: 325–40PubMedCrossRef Suda T, Kamimura K, Kubota T, et al. Progress toward liver-based gene therapy. Hepatol Res 2009; 39: 325–40PubMedCrossRef
181.
Zurück zum Zitat Eastman SJ, Baskin KM, Hodges BL, et al. Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum Gene Ther 2002; 13: 2065–77PubMedCrossRef Eastman SJ, Baskin KM, Hodges BL, et al. Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum Gene Ther 2002; 13: 2065–77PubMedCrossRef
182.
Zurück zum Zitat Yoshino H, Hashizume K, Kobayashi E. Naked plasmidDNA transfer to the porcine liver using rapid injection with large volume. Gene Ther 2006; 13: 1696–702PubMedCrossRef Yoshino H, Hashizume K, Kobayashi E. Naked plasmidDNA transfer to the porcine liver using rapid injection with large volume. Gene Ther 2006; 13: 1696–702PubMedCrossRef
183.
Zurück zum Zitat Alino SF, Herrero MJ, Noguera I, et al. Pig liver gene therapy by noninvasive interventionist catheterism. Gene Ther 2007; 14: 334–43PubMedCrossRef Alino SF, Herrero MJ, Noguera I, et al. Pig liver gene therapy by noninvasive interventionist catheterism. Gene Ther 2007; 14: 334–43PubMedCrossRef
184.
Zurück zum Zitat Fabre JW, Grehan A, Whitehorne M, et al. Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava. Gene Ther 2008; 15: 452–62PubMedCrossRef Fabre JW, Grehan A, Whitehorne M, et al. Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava. Gene Ther 2008; 15: 452–62PubMedCrossRef
185.
Zurück zum Zitat Suda T, Suda K, Liu D. Computer-assisted hydrodynamic gene delivery. Mol Ther 2008; 16: 1098–104PubMedCrossRef Suda T, Suda K, Liu D. Computer-assisted hydrodynamic gene delivery. Mol Ther 2008; 16: 1098–104PubMedCrossRef
186.
Zurück zum Zitat Kamimura K, Suda T, Xu W, et al. Image-guided, lobe-specific hydrodynamic gene delivery to swine liver. Mol Ther 2009; 17: 491–9PubMedCrossRef Kamimura K, Suda T, Xu W, et al. Image-guided, lobe-specific hydrodynamic gene delivery to swine liver. Mol Ther 2009; 17: 491–9PubMedCrossRef
187.
Zurück zum Zitat Kamimura K, Guisheng Z, Liu D. Image-guided, intravascular hydrodynamic gene delivery to skeletal muscle in pigs. Mol Ther 2010; 18: 93–100PubMedCrossRef Kamimura K, Guisheng Z, Liu D. Image-guided, intravascular hydrodynamic gene delivery to skeletal muscle in pigs. Mol Ther 2010; 18: 93–100PubMedCrossRef
189.
Zurück zum Zitat Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244–5PubMedCrossRef Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244–5PubMedCrossRef
Metadaten
Titel
Advances in Gene Delivery Systems
verfasst von
Kenya Kamimura
Takeshi Suda
Guisheng Zhang
Professor Dexi Liu
Publikationsdatum
01.10.2011
Verlag
Springer International Publishing
Erschienen in
Pharmaceutical Medicine / Ausgabe 5/2011
Print ISSN: 1178-2595
Elektronische ISSN: 1179-1993
DOI
https://doi.org/10.1007/BF03256872

Weitere Artikel der Ausgabe 5/2011

Pharmaceutical Medicine 5/2011 Zur Ausgabe

Current Opinion

Diabetes Drugs

Update

Forum